Heart Failure Research Review, Issue 41

In this issue:

NSAIDs and HF risk in Europe
ICDs in nonischaemic systolic HF
Renin-angiotensin system inhibition and all-cause readmission in HF
Survival post-CABG in HFPEF vs. HFREF
Characteristics and outcomes of HF with improved or recovered EF
Anaemia and haematinic deficiencies in chronic HF
Sarcopenia in HFPEF: impact on muscle strength, exercise capacity and QOL
Reversal of LV dysfunction after ablation of PVC-related parameters
Outcomes and predictors of acute-onset cardiomyopathy recovery
Sacubitril/valsartan benefits persist in PARADIGM background therapy subgroups

Please login below to download this issue (PDF)

Subscribe